AstraZeneca Pharma India Ltd

Key details

• Awarding authority: Registrar of Companies, Bengaluru, Karnataka (ROC).
• Nature and scope: Adjudication of penalty for delay in Form MR-2 filing tied to MD appointment.
• Penalty amounts: Rs 1,88,000 on the Company; Rs 50,000 on each officer.
• Order date: 17 September 2026.
• Jurisdiction: Domestic; ROC Bengaluru, Karnataka.
• Related party: No related party or promoter group involvement disclosed.
• MD tenure: Dr. Sanjeev Kumar Panchal served as MD from 01 Jan 2023 to 30 Jun 2025.
• Material impact: Financial penalty disclosed; potential governance/compliance implications.

AstraZeneca Pharma India Limited: Trading Window closed from September 16, 2026 and shall reopen after 48 hours from the declaration of Un-audited Financial Results of the quarter and half year ending September 30, 2026.

Resignation of Senior Management

• Dr. Sandeep Arora resigns as Director of Medical Affairs, BBU and RDBU, effective Sept 15, 2026.
• Company is seeking a suitable replacement for this Senior Management position.
• Cessation of duties will occur at close of business on September 15, 2026.
• Reason: resigning to pursue opportunities outside the company.

ESG rating disclosure

• ESG rating assigned: 64 by Crisil ESG Ratings for FY2026 based on public data.
• Company did not engage Crisil; rating prepared independently by Crisil based on public information.

Order details

• Awarding authority: Hon'ble High Court of Delhi.
• High Court stayed NPPA demand on Betaloc-50 until Feb 10, 2027.
• Company must deposit 15% of the demand amount with the Registrar General.
• Domestic (India) matter; next hearing date Feb 10, 2027.

ESG rating disclosure

• Crisil ESG Ratings assigned an ESG score of 57 for the company based on publicly available information.
• The company did not engage Crisil ESG Ratings; rating prepared independently.
• ESG rating disclosed under SEBI LODR Regulation 30.

Meeting Details

• Date: August 26, 2026; one-on-one, virtual meeting with institutional investor.

Participants

• Company participants' roles not disclosed.

Purpose

• Purpose: one-on-one investor interaction with an institutional investor.

Meeting Details

• Date: August 19, 2026; Type: one-on-one; Mode: virtual; Interaction: institutional investor
• Organiser: AstraZeneca Pharma India Limited

Participants

• Company participants: Company Secretary & Compliance Officer

Purpose

• Purpose: investor interaction

AGM Details

• AGM held on August 10, 2026 via Video Conferencing/Other Audio Visual Means.
• Scrutinizer’s report dated August 11, 2026; all resolutions passed with requisite majority.